Teva Innovative Medicine & Biosimilar Pipeline
By development stage – as of November 1, 2023
Technology Platforms:
Under Regulatory Review
Phase 3
Phase 2
Phase 1
Pre-clinical
Download a PDF version of Teva Innovative Medicine and Biosimilar Pipeline
Download PDFTeva innovative medicine & biosimilar pipeline by development stage, excluding country / regional launches of products submitted or under review in new markets.
Pipeline is current as of November 1, 2023.
-
Back to contents.
In collaboration with MODAG.
-
Back to contents.
Approved and launched in UK, under review EU.
-
Back to contents.
In collaboration with Alvotech for the U.S. market.